Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 1230 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	"The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-Guided Localization' (WGL) in Breast Conserving Surgery for Non-Palpable Breast Cancer: a Randomized Clinical Trial."				Phase III				07/089 ZonMw grant: 80-82310-98-08004, NCT00539474
	11C-Acetate PET/CT Non-FDG-Avid Tumors				No phase specified				TASMC-08-EE-109-CTIL NCT00687778
	18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology				Phase III				R05-0076 NCT00207298
	1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy				Phase II				ACORN AC01B07 NCT00493636
	24 Months of Exemestane or Letrozole to Treat Breast Cancer				No phase specified				UMCC 2005.074 NCT00263913
	2-Arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab				Phase III				CECOG/BC1.3.005 NCT00600340
	3'-deoxy-3'-18F Fluorothymidine PET/CT Scanning in Patients Undergoing Treatment for Stage III Breast Cancer				Phase II				MCV-HM11081 HM11081, 8029, NCT00566293
	3-Dimensional Form and Soft Tissue Biomechanics of the Breast				No phase specified				ID01-305 NCT00502814
	5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Advanced Solid Tumors				Phase I				NCI-06-C-0221 NCI-P7001, CCC-PHI-16, NCT00378807
	A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer				Phase I				ANX 514-01 NCT00664170


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute